Hyperion DeFi, Inc. (HYPD)Healthcare | Biotechnology | Dallas, United States | NasdaqCM
3.26 USD
-0.36
(-9.945%) ⇩
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 3.25 -0.01 (-0.010%) ⇩ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 3:01 a.m. EDT
The immediate outlook remains neutral due to a lack of clear directional momentum, despite a recent bounce off the lows. While the stock has rallied roughly 10% over the last month, it still trades significantly below its 200-day average, suggesting the broader trend remains downward. The statistical forecast offers no guidance, reflecting the high volatility and noise inherent in this speculative vehicle. From a long-term perspective, the investment case is severely compromised by a catastrophic multi-year decline. Over the past seven years, the asset has lost nearly 99% of its value, with the last two years showing double-digit percentage drops. This trajectory indicates a fundamental breakdown in the business model or market perception, rendering any current valuation metrics irrelevant. The company is burning through cash, reporting massive negative free cash flow, and carrying significant debt relative to its tiny equity base. Despite a 'strong buy' analyst recommendation based on a distant target price, the reality of the balance sheet and the relentless price destruction suggest this is a value trap rather than a bargain. There is no income component to consider, as the company has not issued any dividends in the last five years. Investors seeking yield or capital preservation should avoid this security entirely. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.213608 |
| AutoETS | 0.218305 |
| AutoTheta | 0.224593 |
| AutoARIMA | 0.235641 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 35% |
| H-stat | 2.58 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.481 |
| Excess Kurtosis | -0.45 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 8.743 |
| Revenue per Share | 0.143 |
| Market Cap | 50,658,556 |
| Beta | 2.50 |
| Profit Margins | 474.87% |
| Previous Name | Eyenovia, Inc. |
| Website | https://hyperiondefi.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.38954467 |
| Address1 | 3,090 Nowitzki Way |
| Address2 | Suite 300 |
| All Time High | 859.2 |
| All Time Low | 0.85 |
| Ask | 3.3 |
| Ask Size | 1 |
| Average Analyst Rating | 1.0 - Strong Buy |
| Average Daily Volume10 Day | 774,250 |
| Average Daily Volume3 Month | 511,856 |
| Average Volume | 511,856 |
| Average Volume10Days | 774,250 |
| Beta | 2.501 |
| Bid | 2.63 |
| Bid Size | 2 |
| Book Value | 6.662 |
| City | Dallas |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.26 |
| Current Ratio | 2.343 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 3.68 |
| Day Low | 3.24 |
| Debt To Equity | 8.743 |
| Display Name | Hyperion DeFi |
| Earnings Call Timestamp End | 1,786,568,400 |
| Earnings Call Timestamp Start | 1,786,568,400 |
| Earnings Timestamp | 1,786,564,800 |
| Earnings Timestamp End | 1,794,513,600 |
| Earnings Timestamp Start | 1,794,513,600 |
| Ebitda Margins | 0.0 |
| Enterprise To Revenue | 35.649 |
| Enterprise Value | 49,933,780 |
| Eps Trailing Twelve Months | -3.47 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.9532 |
| Fifty Day Average Change | 0.3067999 |
| Fifty Day Average Change Percent | 0.10388727 |
| Fifty Two Week Change Percent | -38.954468 |
| Fifty Two Week High | 15.0 |
| Fifty Two Week High Change | -11.74 |
| Fifty Two Week High Change Percent | -0.7826666 |
| Fifty Two Week Low | 2.34 |
| Fifty Two Week Low Change | 0.9200001 |
| Fifty Two Week Low Change Percent | 0.39316243 |
| Fifty Two Week Range | 2.34 - 15.0 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,516,890,600,000 |
| Float Shares | 13,781,147 |
| Free Cashflow | -14,804,011 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 9 |
| Fullday Change | -0.36 |
| Fullday Change Percent | -9.94475 |
| Fullday Price | 3.25 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.78350997 |
| Gross Profits | 1,097,457 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13492 |
| Held Percent Institutions | 0.18004999 |
| Implied Shares Outstanding | 15,539,434 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,738,540,800 |
| Last Split Factor | 1:80 |
| Long Business Summary | Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas. |
| Long Name | Hyperion DeFi, Inc. |
| Market | us_market |
| Market Cap | 50,658,556 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_291491698 |
| Most Recent Quarter | 1,782,777,600 |
| Name Change Date | 2,026-08-29 |
| Net Income To Common | -17,848,348 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 56,097,356 |
| Number Of Analyst Opinions | 2 |
| Open | 3.56 |
| Operating Cashflow | -13,974,364 |
| Operating Margins | -7.5750704 |
| Payout Ratio | 0.0 |
| Phone | 833 393 6684 |
| Post Market Change | -0.00999999 |
| Post Market Change Percent | -0.30674818 |
| Post Market Price | 3.25 |
| Post Market Time | 1,787,959,804 |
| Prev Name | Eyenovia, Inc. |
| Previous Close | 3.62 |
| Price Hint | 4 |
| Price To Book | 0.4893425 |
| Price To Sales Trailing12 Months | 36.166626 |
| Profit Margins | 4.74872 |
| Quick Ratio | 1.817 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.0 |
| Region | US |
| Regular Market Change | -0.36 |
| Regular Market Change Percent | -9.94475 |
| Regular Market Day High | 3.68 |
| Regular Market Day Low | 3.24 |
| Regular Market Day Range | 3.24 - 3.68 |
| Regular Market Open | 3.56 |
| Regular Market Previous Close | 3.62 |
| Regular Market Price | 3.26 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 1,004,551 |
| Return On Assets | -0.110649996 |
| Return On Equity | 0.0955 |
| Revenue Per Share | 0.143 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 15,539,434 |
| Shares Percent Shares Out | 0.0991 |
| Shares Short | 1,539,670 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 1,532,254 |
| Short Name | Hyperion DeFi, Inc. |
| Short Percent Of Float | 0.102299996 |
| Short Ratio | 7.17 |
| Source Interval | 15 |
| State | TX |
| Symbol | HYPD |
| Target High Price | 7.3 |
| Target Low Price | 7.1 |
| Target Mean Price | 7.2 |
| Target Median Price | 7.2 |
| Total Cash | 9,637,216 |
| Total Cash Per Share | 0.62 |
| Total Debt | 8,911,919 |
| Total Revenue | 1,400,699 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -3.47 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.47445 |
| Two Hundred Day Average Change | -0.21445012 |
| Two Hundred Day Average Change Percent | -0.061722033 |
| Type Disp | Equity |
| Volume | 1,004,551 |
| Website | https://hyperiondefi.com |
| Zip | 75,219 |